Previous Close | 7.91 |
Open | 7.91 |
Bid | 8.05 x 900 |
Ask | 8.43 x 1100 |
Day's Range | 7.67 - 8.17 |
52 Week Range | 7.56 - 16.68 |
Volume | |
Avg. Volume | 306,317 |
Market Cap | 559.055M |
Beta (5Y Monthly) | 0.02 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.94 |
Earnings Date | Aug 01, 2022 - Aug 05, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.75 |
Subscribe to Yahoo Finance Plus to view Fair Value for KNSA
Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) came out with its first-quarter results last week, and we wanted to see...
Kiniksa Pharmaceuticals, Ltd. (KNSA) delivered earnings and revenue surprises of 30.77% and 0.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
HAMILTON, Bermuda, May 02, 2022 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, May 3, 2022, at 8:30 a.m. Eastern Time to report its first quarter 2022 financial results and corporate activities. A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately